Condition
Kernicterus
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Unknown1
Withdrawn1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06058910Completed
Bilistick Point-of-care System 2.0 Bilirubin Validation
NCT03534466Not ApplicableTerminated
Evaluation of Long-Term Gait Development in Infants With Neonatal Encephalopathy Using Infant Treadmill
NCT03527498Not ApplicableWithdrawn
Evaluation of Long-term Neurodevelopment in Neonatal Encephalopathy by Infant Treadmill
NCT02691156Completed
Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants
NCT03195049Not ApplicableUnknownPrimary
Complications of Exchange Transfusion in Neonates
NCT02713464Not ApplicableCompletedPrimary
Does Maternal Instruction Prevent Kernicterus in Nigeria?
Showing all 6 trials